Cargando…

HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact

Human T-cell leukemia virus-1 (HTLV-1) is a neglected and incurable retrovirus estimated to infect 5 to 10 million worldwide. Specific indigenous Australian populations report infection rates of more than 40%, suggesting a potential evolution of the virus with global implications. HTLV-1 causes adul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinto, Daniel O., DeMarino, Catherine, Pleet, Michelle L., Cowen, Maria, Branscome, Heather, Al Sharif, Sarah, Jones, Jennifer, Dutartre, Helene, Lepene, Benjamin, Liotta, Lance A., Mahieux, Renaud, Kashanchi, Fatah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759572/ https://www.ncbi.nlm.nih.gov/pubmed/31620104 http://dx.doi.org/10.3389/fmicb.2019.02147

Ejemplares similares

Extracellular vesicles from HTLV-1 infected cells modulate target cells and viral spread
por: Pinto, Daniel O., et al.
Publicado: (2021)

STLV-1 as a model for studying HTLV-1 infection
por: Jégado, Brice, et al.
Publicado: (2019)

Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles
por: Pleet, Michelle L, et al.
Publicado: (2018)

Extracellular Vesicles from Infected Cells Are Released Prior to Virion Release
por: Kim, Yuriy, et al.
Publicado: (2021)

Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger
por: Al Sharif, Sarah, et al.
Publicado: (2020)

Cannabinoids Reduce Extracellular Vesicle Release from HIV-1 Infected Myeloid Cells and Inhibit Viral Transcription
por: DeMarino, Catherine, et al.
Publicado: (2022)

An Omics Approach to Extracellular Vesicles from HIV-1 Infected Cells
por: Barclay, Robert A., et al.
Publicado: (2019)

Identification of Modulators of HIV-1 Proviral Transcription from a Library of FDA-Approved Pharmaceuticals
por: Sampey, Gavin C., et al.
Publicado: (2020)

Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Use of Stem Cell Extracellular Vesicles as a “Holistic” Approach to CNS Repair
por: Branscome, Heather, et al.
Publicado: (2020)

HTLV-1 infection of myeloid cells: from transmission to immune alterations
por: Rocamonde, Brenda, et al.
Publicado: (2019)

Publisher Correction: Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells
por: DeMarino, Catherine, et al.
Publicado: (2018)

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
por: Pleet, Michelle L., et al.
Publicado: (2019)

Methamphetamine Induces the Release of Proadhesive Extracellular Vesicles and Promotes Syncytia Formation: A Potential Role in HIV-1 Neuropathogenesis
por: Chand, Subhash, et al.
Publicado: (2022)

HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment
por: Futsch, Nicolas, et al.
Publicado: (2017)

Autophagy, EVs, and Infections: A Perfect Question for a Perfect Time
por: Pleet, Michelle L., et al.
Publicado: (2018)

A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system
por: Williams, Anastasia, et al.
Publicado: (2021)

Presence of Viral microRNA in Extracellular Environments
por: DeMarino, Catherine, et al.
Publicado: (2017)

Cytokine Networks Dysregulation during HTLV-1 Infection and Associated Diseases
por: Futsch, Nicolas, et al.
Publicado: (2018)

Distinct DC subsets are not equally susceptible to HTLV-1 infection
por: Alais, Sandrine, et al.
Publicado: (2014)

Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells
por: Rizkallah, Gergès, et al.
Publicado: (2017)

Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway
por: Barclay, Robert A., et al.
Publicado: (2020)

Correction: Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells
por: Rizkallah, Gergès, et al.
Publicado: (2017)

Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage
por: Branscome, Heather, et al.
Publicado: (2022)

Exosomes derived from HTLV-1 infected cells contain viral proteins and mRNA
por: Jaworski, Elizabeth, et al.
Publicado: (2015)

Extracellular vesicles from infected cells: potential for direct pathogenesis
por: Schwab, Angela, et al.
Publicado: (2015)

Sensing of cell-associated HTLV by plasmacytoid dendritic cells is regulated by dense β-galactoside glycosylation
por: Assil, Sonia, et al.
Publicado: (2019)

Comparative infection of autologous primary T cells and monocytes derived DCs using cell-free virus preparation, viral biofilm, pseudotyped-virus or viral synapse
por: Alais, Sandrine, et al.
Publicado: (2014)

Differences in Transcriptional Dynamics Between T-cells and Macrophages as Determined by a Three-State Mathematical Model
por: DeMarino, Catherine, et al.
Publicado: (2020)

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2016)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2018)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Reverse-phase phosphoproteome analysis (RPMA) of signaling pathways induced by HTLV-1 infection
por: Popova, Taissia G, et al.
Publicado: (2011)

Low-Level Ionizing Radiation Induces Selective Killing of HIV-1-Infected Cells with Reversal of Cytokine Induction Using mTOR Inhibitors
por: Pinto, Daniel O., et al.
Publicado: (2020)

How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy
por: Pasquier, Amandine, et al.
Publicado: (2018)

Localization and Sub-Cellular Shuttling of HTLV-1 Tax with the miRNA Machinery
por: Van Duyne, Rachel, et al.
Publicado: (2012)

Localization and sub-cellular shuttling of HTLV-1 Tax with the microRNA machinery
por: Van Duyne, Rachel, et al.
Publicado: (2014)

Effect of transcription inhibition and generation of suppressive viral non-coding RNAs
por: Pinto, Daniel O., et al.
Publicado: (2019)

ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity
por: Cachat, Anne, et al.
Publicado: (2014)

Microbial Biofilms: Human T-cell Leukemia Virus Type 1 First in Line for Viral Biofilm but Far Behind Bacterial Biofilms
por: Maali, Yousef, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ie55lngvvevommhcuj3nugd3e